LUNG Pulmonx
- 7.710
- +0.600+8.44%
- 7.800
- +0.090+1.17%
Pulmonx News
Pulmonx to Present at the Stifel 2024 Healthcare Conference
Stifel Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $16
Analyst Estimates: Here's What Brokers Think Of Pulmonx Corporation (NASDAQ:LUNG) After Its Third-Quarter Report
Pulmonx | 10-Q: Q3 2024 Earnings Report
Pulmonx Analyst Ratings
Stifel Maintains Pulmonx(LUNG.US) With Buy Rating, Cuts Target Price to $16
CCORF Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $16
Piper Sandler Maintains Pulmonx(LUNG.US) With Buy Rating, Cuts Target Price to $10
Pulmonx Corporation (LUNG) Q3 2024 Earnings Call Transcript Summary
Pulmonx Corporation (LUNG) Reports Q3 Loss, Misses Revenue Estimates
Pulmonx GAAP EPS of $0.36 Beats by $0.81, Revenue of $20.4M Beats by $0.12M
Earnings Flash (LUNG) PULMONX CORPORATION Reports Q3 Revenue $20.4M
Express News | Pulmonx Q3 Income From Operations USD -14.129 Million Vs. IBES Estimate USD -17.7 Million
Express News | Pulmonx Outlook FY Revenue USD 81-84 Million
Pulmonx 3Q Loss/Shr 36c >LUNG
Earnings Preview For Pulmonx
Lake Street Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $12
Earnings Preview: Pulmonx to Report Financial Results Post-market on October 30
$Pulmonx(LUNG.US)$ is scheduled to release its financial results post-market on October 30 ET. Earnings PreviewAnalysts estimate $Pulmonx(LUNG.US)$ to post revenue of USD20.28M for 2024Q3, up 14.81%
Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024
Stifel Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $17
Analysis
Price Target
No Data
No Data